Liver transplant for fulminant hepatic failure.
Fulminant hepatic failure is a challenging indication for liver transplantation because of associated multiple organ failure, profound neurologic abnormalities and coagulopathy. Sixteen patients have undergone emergent orthotopic liver transplantation for this indication at the University of Michigan, Ann Arbor, Michigan. Despite the associated problems, patient survival (68.2% at 2 years), intra-operative blood product utilization and duration of surgery were comparable to patients receiving liver transplants for other indications. All patients experienced complete recovery from preoperative neurologic abnormalities. Recurrent viral hepatitis did occur but did not result in allograft loss. For selected patients, orthotopic liver transplantation is excellent therapy for patients presenting with fulminant hepatic failure.
Campbell
D A
DA
Department of Surgery, University of Michigan Medical Center, Ann Arbor 48109-0331.
Ham
J M
JM
McCurry
K R
KR
Lucey
M R
MR
Turcotte
J G
JG
Merion
R M
RM
D000293:Adolescent; D000328:Adult; D000368:Aged; D001803:Blood Transfusion / Q000706:statistics & numerical data; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006501:Hepatic Encephalopathy / Q000401:mortality / Q000601:surgery*; D006801:Humans; D015994:Incidence; D016031:Liver Transplantation / Q000379:methods / Q000592:standards*; D008297:Male; D008824:Michigan / Q000453:epidemiology; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology* / Q000209:etiology; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome